Yew Bio-Pharm Group Retained Earnings (Accumulated Deficit) 2012-2021 | YEWB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Yew Bio-Pharm Group retained earnings (accumulated deficit) from 2012 to 2021. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Yew Bio-Pharm Group Retained Earnings (Accumulated Deficit) 2012-2021 | YEWB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Corteva (CTVA)	$40.8B
Archer Daniels Midland (ADM)	$22.9B
FMC (FMC)	$4.7B
Fresh Del Monte Produce (FDP)	$1.6B
Dole (DOLE)	$1.3B
Adecoagro S.A (AGRO)	$1.1B
Cresud S.A.C.I.F Y A (CRESY)	$750M
Mission Produce (AVO)	$725M
Calavo Growers (CVGW)	$467M
Brasilagro Cia Brasileira De Propriedades Agricolas (LND)	$399M
Limoneira Co (LMNR)	$289M
Bioceres Crop Solutions (BIOX)	$260M
Forafric Global (AFRI)	$230M
Alico (ALCO)	$225M
Cadiz (CDZI)	$222M
PYXUS INTERNATIONAL, INC (PYYX)	$101M
Cibus (CBUS)	$55M
Local Bounti (LOCL)	$38M
Moolec Science SA (MLEC)	$26M
Davis Commodities (DTCK)	$12M
S&W Seed (SANW)	$10M
Origin Agritech (SEED)	$10M
N2OFF (NITO)	$4M
Edible Garden AG (EDBL)	$3M
AgriFORCE Growing Systems (AGRI)	$2M
Farmmi (FAMI)	$2M
Lavoro (LVRO)	$0M
CHS Inc (CHSCP)	$0M